Clinical Trial Results: Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information: Administrative Supplement Study [Phase 2]

View source ↗

Summary

Phase 2 administrative supplement study investigating rejection of personalized breast cancer risk information.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Colorado, Denver | Conditions: Breast Cancer Female | Phase 2 | Status: COMPLETED | Results posted: 2026-08-03